The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines
- PMID: 12727836
The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines
Abstract
Epithelial-mesenchymal transition (EMT) is an important process during development and oncogenesis by which epithelial cells acquire fibroblast-like properties and show reduced intercellular adhesion and increased motility. Squamous cell carcinoma lines engineered to express constitutively active Akt underwent EMT, characterized by down-regulation of the epithelial markers desmoplakin, E-cadherin, and beta-catenin and up-regulation of the mesenchymal marker vimentin. The cells lost epithelial cell morphology and acquired fibroblast-like properties. Additionally, E-cadherin was down-regulated transcriptionally. The cells expressing constitutively active Akt exhibited reduced cell-cell adhesion, increased motility on fibronectin-coated surfaces, and increased invasiveness in animals. AKT is activated in many human carcinomas, and the AKT-driven EMT may confer the motility required for tissue invasion and metastasis. These findings suggest that future therapies based on AKT inhibition may complement conventional treatments by controlling tumor cell invasion and metastasis.
Similar articles
-
Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.J Exp Clin Cancer Res. 2009 Feb 26;28(1):28. doi: 10.1186/1756-9966-28-28. J Exp Clin Cancer Res. 2009. PMID: 19243631 Free PMC article.
-
Epithelial-mesenchymal transition during invasion of cutaneous squamous cell carcinoma is paralleled by AKT activation.Br J Dermatol. 2014 Nov;171(5):1014-21. doi: 10.1111/bjd.12967. Epub 2014 Oct 6. Br J Dermatol. 2014. PMID: 24628329
-
Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression.J Pathol. 2008 Jul;215(3):330-9. doi: 10.1002/path.2365. J Pathol. 2008. PMID: 18491351
-
Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.Oncogene. 2005 Nov 14;24(50):7443-54. doi: 10.1038/sj.onc.1209091. Oncogene. 2005. PMID: 16288291 Review.
-
Role of glycogen synthase kinase-3 in cell fate and epithelial-mesenchymal transitions.Cells Tissues Organs. 2007;185(1-3):73-84. doi: 10.1159/000101306. Cells Tissues Organs. 2007. PMID: 17587811 Review.
Cited by
-
Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients.Cancer Manag Res. 2021 Apr 7;13:3055-3065. doi: 10.2147/CMAR.S299624. eCollection 2021. Cancer Manag Res. 2021. PMID: 33854375 Free PMC article.
-
PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population.J Biol Chem. 2012 Jun 1;287(23):19516-27. doi: 10.1074/jbc.M111.337428. Epub 2012 Apr 16. J Biol Chem. 2012. PMID: 22511756 Free PMC article.
-
LncRNA NEAT1 mediates progression of oral squamous cell carcinoma via VEGF-A and Notch signaling pathway.World J Surg Oncol. 2020 Oct 6;18(1):261. doi: 10.1186/s12957-020-02028-x. World J Surg Oncol. 2020. PMID: 33023572 Free PMC article.
-
PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancer.Am J Pathol. 2012 Mar;180(3):1017-1027. doi: 10.1016/j.ajpath.2011.11.021. Epub 2011 Dec 28. Am J Pathol. 2012. PMID: 22209699 Free PMC article.
-
Cutaneous carcinosarcoma and the EMT: to transition, or not to transition? That is the question.Virchows Arch. 2015 Mar;466(3):359-60. doi: 10.1007/s00428-015-1718-7. Epub 2015 Jan 27. Virchows Arch. 2015. PMID: 25619916 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous